Gene · 7486
Papers3,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phospho-Ku70 induced by DNA damage interacts with RNA Pol II and promotes the formation of phospho-53BP1 foci to ensure optimal cNHEJ. | Nucleic Acids Res | 2021 | 34718776 | PubTator, text mining | PubMed |
| DNA Damage Repair Deficiency in Pancreatic Ductal Adenocarcinoma: Preclinical Models and Clinical Perspectives. | Front Cell Dev Biol | 2021 | 34712667 | PubTator, text mining | PubMed |
| Targeting DNA Repair Response Promotes Immunotherapy in Ovarian Cancer: Rationale and Clinical Application. | Front Immunol | 2021 | 34712221 | PubTator, text mining | PubMed |
| SARS-CoV-2-host proteome interactions for antiviral drug discovery. | Mol Syst Biol | 2021 | 34709727 | PubTator, text mining | PubMed |
| Targeting BRCA and DNA Damage Repair Genes in GI Cancers: Pathophysiology and Clinical Perspectives. | Front Oncol | 2021 | 34707985 | PubTator, text mining | PubMed |
| Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients. | NPJ Precis Oncol | 2021 | 34707195 | PubTator, text mining | PubMed |
| A trans-omic Mendelian randomization study of parental lifespan uncovers novel aging biology and therapeutic candidates for chronic diseases. | Aging Cell | 2021 | 34704651 | PubTator, text mining | PubMed |
| Analysis of whole exome sequencing in severe mental illness hints at selection of brain development and immune related genes. | Sci Rep | 2021 | 34702870 | PubTator, text mining | PubMed |
| The Expression and Function of Circadian Rhythm Genes in Hepatocellular Carcinoma. | Oxid Med Cell Longev | 2021 | 34697563 | PubTator, text mining | PubMed |
| Genomic Signatures in HPV-Associated Tumors. | Viruses | 2021 | 34696429 | PubTator, text mining | PubMed |
| The Effect of Atypical Nucleic Acids Structures in DNA Double Strand Break Repair: A Tale of R-loops and G-Quadruplexes. | Front Genet | 2021 | 34691154 | PubTator, text mining | PubMed |
| DNA Damage Response and Cell Cycle Regulation in Pluripotent Stem Cells. | Genes (Basel) | 2021 | 34680943 | PubTator, text mining | PubMed |
| Neuregulin 1 Gene (NRG1). A Potentially New Targetable Alteration for the Treatment of Lung Cancer. | Cancers (Basel) | 2021 | 34680187 | PubTator, text mining | PubMed |
| Post-Translational Modifications of PCNA in Control of DNA Synthesis and DNA Damage Tolerance-the Implications in Carcinogenesis. | Int J Biol Sci | 2021 | 34671219 | PubTator, text mining | PubMed |
| Identification of a novel pathogenic variant in PALB2 and BARD1 genes by a multigene sequencing panel in triple negative breast cancer in Morocco. | J Genomics | 2021 | 34646395 | PubTator, text mining | PubMed |
| Wee1 Kinase: A Potential Target to Overcome Tumor Resistance to Therapy. | Int J Mol Sci | 2021 | 34639030 | PubTator, text mining | PubMed |
| Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma Therapy. | Int J Mol Sci | 2021 | 34638744 | PubTator, text mining | PubMed |
| Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia-From Molecular Mechanisms to Clinical Relevance. | Cancers (Basel) | 2021 | 34638304 | PubTator, text mining | PubMed |
| A Risk Score Model Incorporating Three m6A RNA Methylation Regulators and a Related Network of miRNAs-m6A Regulators-m6A Target Genes to Predict the Prognosis of Patients With Ovarian Cancer. | Front Cell Dev Biol | 2021 | 34631700 | PubTator, text mining | PubMed |
| The Contribution of Physiological and Accelerated Aging to Cancer Progression Through Senescence-Induced Inflammation. | Front Oncol | 2021 | 34621683 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7486/papers?page=39